Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin for Treatment of Obsessive Compulsive Disorder

NCT03300947 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT03300947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03300947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin for Treatment of Obsessive Compulsive Disorder
Lead sponsor
University of Arizona
Phase
Phase 1
Overall status
Completed
Start date
January 2, 2019
Completion date
December 30, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive-compulsive disorder (ocd)